top of page
10-Year Cancer Plan: One Cancer Voice Consensus Statement
Cancer52 have joined 53 other cancer charities as One Cancer Voice to agree a Consensus Statement for submission as part of the...
2021 All Stakeholder Briefing Report
On Wednesday 13th October 2021, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common...


Annual Review 2020-21
Cancer52 is delighted to present its Annual Review 2020-21. This report particularly highlights the strength and impact of Cancer52’s...


2021 All Stakeholder Briefing
On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...
2021 All Stakeholder Briefing - Follow Up
On Wednesday 13th October, we hosted our Annual All Stakeholder Briefing, focusing on Early diagnosis for rare and less common cancers:...
Cancer52 - 2021 All Stakeholder Briefing
Cancer52's All Stakeholder Briefing will take place (virtually) on Wednesday 13th October 2021 from 09:30am until 12:30pm. The focus for...


Launch of Do You C Us? campaign
We are pleased to have partnered with Pfizer to launch the Do You C Us? Campaign. The Do You C Us? Campaign aims to raise awareness of...
The impact of the Covid-19 pandemic on people with rare and less common cancers - Report published
Working with Keep up with Cancer[i] Cancer52 has published a new report which covers the impact of Covid-19 on people with rare and less...
Review of Psychosocial Support undertaken by Cancer52 members during covid-19
A review of the work of 13 Cancer52 charities undertaken to provide psychosocial support to people with rare and less common cancers...
The NICE Response
The final response, including the full list of charities who signed up, has now been submitted. If you would like to see a copy of this...
bottom of page
